Congress May Overturn Some Agency Rules, & More from CRS
“With a change of presidential administrations taking place in January, some in Congress are paying renewed attention to a parliamentary mechanism that might enable the new Congress and the new President to overturn agency final rules of the Obama Administration issued after late-May 2016,” a newly updated brief from the Congressional Research Service explains.
“The inauguration of Republican Donald J. Trump as President in 2017 may present a finite window during which the [congressional] disapproval mechanism might be used more successfully.” See Agency Final Rules Submitted After May 30, 2016, May Be Subject to Disapproval in 2017 Under the Congressional Review Act, CRS Insight, updated November 9, 2016.
Other new and updated reports from the Congressional Research Service include the following.
Legislative Actions to Repeal, Defund, or Delay the Affordable Care Act, updated November 10, 2016
“Regulatory Relief” for Banking: Selected Legislation in the 114th Congress, updated November 10, 2016
Retirement Benefits for Members of Congress, updated November 10, 2016
Staff Tenure in Selected Positions in Senate Committees, 2006-2016, November 9, 2016
Staff Tenure in Selected Positions in Senators’ Offices, 2006-2016, November 9, 2016
Staff Tenure in Selected Positions in House Committees, 2006-2016, November 9, 2016
Staff Tenure in Selected Positions in House Member Offices, 2006-2016, November 9, 2016
U.S. Trade with Free Trade Agreement (FTA) Partners, updated November 9, 2016
China Issues Decision on Hong Kong Legislative Council Controversy, CRS Insight, November 9, 2016
Navy Force Structure: A Bigger Fleet? Background and Issues for Congress, updated November 9, 2016
Confirmation that the construction of the security perimeter and associated security infrastructure at RAF Lakenheath are still ongoing once again raises questions about whether U.S. nuclear weapons have already been deployed to the base.
Alaskans are sensibly pulling back from the vogue for bans and returning to a western tradition that has worked for more than half a century – one that welcomes innovation but also oversees it closely.
The strength of our nation’s data policy isn’t just in the rules we write, but in how effectively we translate those rules into a system that prioritizes the public good. Join us in this movement to design and build more resilient national data policies.
The human cost is measured in deaths. The financial cost is measured in the $52 billion taxpayers pay annually end stage renal disease – double NASA’s budget.